X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4432) 4432
Publication (35) 35
Dissertation (23) 23
Book Chapter (19) 19
Conference Proceeding (3) 3
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2731) 2731
apoe (2092) 2092
male (1988) 1988
female (1954) 1954
alzheimer's disease (1674) 1674
aged (1573) 1573
neurosciences (1519) 1519
apolipoproteins e - genetics (1431) 1431
genotype (1397) 1397
middle aged (1233) 1233
apolipoproteins (1159) 1159
alzheimers-disease (1142) 1142
apoe genotype (1110) 1110
dementia (1093) 1093
apolipoprotein e (1046) 1046
risk factors (1013) 1013
clinical neurology (942) 942
alzheimer disease - genetics (897) 897
aged, 80 and over (892) 892
risk (827) 827
association (728) 728
alleles (654) 654
adult (639) 639
apolipoprotein e4 - genetics (624) 624
apolipoprotein-e (612) 612
geriatrics & gerontology (605) 605
genetic aspects (574) 574
neurology (561) 561
animals (496) 496
brain (495) 495
psychiatry (486) 486
age (479) 479
mild cognitive impairment (472) 472
genetic predisposition to disease (459) 459
alzheimer’s disease (418) 418
aging (408) 408
polymorphism (391) 391
allele (388) 388
analysis (384) 384
cholesterol (384) 384
genetics (383) 383
apolipoprotein e4 (377) 377
lipids (376) 376
mice (376) 376
apolipoprotein-e genotype (374) 374
polymorphism, genetic (373) 373
memory (371) 371
gene frequency (370) 370
neuropsychological tests (370) 370
research (370) 370
cognition (361) 361
e genotype (328) 328
biochemistry & molecular biology (313) 313
alzheimers disease (312) 312
genetics & heredity (304) 304
population (297) 297
atherosclerosis (296) 296
case-control studies (296) 296
disease (289) 289
magnetic resonance imaging (279) 279
gene (266) 266
cognitive ability (264) 264
neurodegenerative diseases (259) 259
alzheimer disease - pathology (257) 257
internal medicine (254) 254
e polymorphism (249) 249
cohort studies (238) 238
pathology (238) 238
cognitive decline (237) 237
apolipoproteins e - metabolism (235) 235
genes (233) 233
alzheimer disease (221) 221
genotypes (220) 220
biomarkers (216) 216
onset (216) 216
polymorphism, single nucleotide (214) 214
brain - pathology (207) 207
genome-wide association (207) 207
cell biology (203) 203
diagnosis (203) 203
alzheimer disease - metabolism (202) 202
physiological aspects (199) 199
proteins (199) 199
genetic research (195) 195
metabolism (193) 193
health aspects (189) 189
medical research (189) 189
neuroimaging (189) 189
risk-factors (189) 189
phenotype (188) 188
studies (184) 184
prevalence (182) 182
genetic predisposition to disease - genetics (181) 181
decline (180) 180
longitudinal studies (179) 179
apolipoprotein-e polymorphism (178) 178
expression (177) 177
protein (177) 177
alzheimer disease - epidemiology (174) 174
cognition disorders - genetics (173) 173
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4427) 4427
Chinese (39) 39
Spanish (22) 22
Portuguese (20) 20
French (11) 11
Russian (8) 8
German (5) 5
Korean (5) 5
Japanese (4) 4
Polish (4) 4
Czech (3) 3
Italian (1) 1
Norwegian (1) 1
Persian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA neurology, ISSN 2168-6149, 06/2013, Volume 70, Issue 8, pp. 1 - 9
Journal Article
Neurobiology of aging, ISSN 0197-4580, 2017, Volume 51, pp. 104 - 112
.... However, this measure was not changed during preclinical or prodromal AD and was not associated with amyloid PET or APOE genotype... 
Neurology | Internal Medicine | APOE ε4 | Amyloid | Diabetes | Blood-brain barrier | Vascular pathology | Dementia | ALZHEIMERS-DISEASE | COGNITIVE IMPAIRMENT | APOE epsilon 4 | FRONTOTEMPORAL LOBAR DEGENERATION | CEREBROSPINAL-FLUID | DEPENDENT MANNER | NEUROSCIENCES | GERIATRICS & GERONTOLOGY | TIGHT JUNCTIONS | VASCULAR DEMENTIA | DYSFUNCTION | DIAGNOSTIC-CRITERIA | LEWY BODIES | Diabetes Mellitus - blood | Capillary Permeability | Humans | Middle Aged | Blood-Brain Barrier - physiopathology | Immunoglobulins - cerebrospinal fluid | Vascular Endothelial Growth Factor A - cerebrospinal fluid | Cell Adhesion Molecules - cerebrospinal fluid | Genotype | Male | Diabetes Mellitus - cerebrospinal fluid | Dementia - etiology | Serum Albumin | Cell Adhesion Molecule-1 | Apolipoproteins E - genetics | Amyloid beta-Peptides - metabolism | Aged, 80 and over | Albumins - cerebrospinal fluid | Diabetes Mellitus - etiology | Female | Aged | Cohort Studies | Nervous system diseases | Neurosciences | PET imaging | Endothelial growth factors | Physiological aspects | Brain damage | Genetic aspects | Permeability | Apolipoproteins | Alzheimer's disease | Endothelium | Medical research | Medicine, Experimental | lewy bodies | vascular dementia | Geriatrics & Gerontology | Neurosciences & Neurology | dependent manner | dysfunction | cerebrospinal-fluid | Endokrinologi och diabetes | diagnostic-criteria | cognitive impairment | tight junctions | Geriatrik | frontotemporal lobar degeneration | Neurovetenskaper | Endocrinology and Diabetes | Geriatrics | alzheimers-disease
Journal Article
The Journal of biological chemistry, ISSN 1083-351X, 2014, Volume 289, Issue 44, pp. 30538 - 30555
Previous data demonstrate that bexarotene (Bex), retinoid X receptor (RXR) agonist, reduces soluble and insoluble amyloid-beta (A beta) in Alzheimer disease... 
BEXAROTENE THERAPY | ABCA1 | ALZHEIMERS-DISEASE | DEPOSITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | LIVER | A-BETA | TRANSGENIC MOUSE MODEL | MILD COGNITIVE IMPAIRMENT | BRAIN | APOLIPOPROTEIN-E | Disks Large Homolog 4 Protein | Liver - pathology | Nicotinic Acids - pharmacokinetics | Humans | Male | Tetrahydronaphthalenes - adverse effects | ATP Binding Cassette Transporter 1 - metabolism | Liver - drug effects | Tetrahydronaphthalenes - administration & dosage | Amyloid beta-Peptides - metabolism | Lipoproteins - metabolism | ATP-Binding Cassette Transporters - metabolism | Membrane Proteins - metabolism | Nicotinic Acids - administration & dosage | Drug Evaluation, Preclinical | Nicotinic Acids - adverse effects | Retinoid X Receptors - metabolism | ATP Binding Cassette Transporter, Subfamily G, Member 1 | Bexarotene | Peptide Fragments - metabolism | Administration, Oral | Mice, Inbred C57BL | Solubility | Alzheimer Disease - drug therapy | Tetrahydronaphthalenes - pharmacokinetics | Genotype | Mice, Transgenic | Organ Size - drug effects | Animals | Retinoid X Receptors - agonists | Apolipoproteins E - genetics | Guanylate Kinases - metabolism | Index Medicus | Molecular Bases of Disease | Oligomeric Aβ | Alzheimer Disease | Drug Delivery | Aβ Complex | Apolipoprotein E (ApoE) | Amyloid-β (AB) | RXR Agonists | Hepatomegaly | ABCG1 Lipid Transporters | Drug Action | ApoE
Journal Article
Journal of the American Geriatrics Society (JAGS), ISSN 0002-8614, 12/2016, Volume 64, Issue 12, pp. 2479 - 2486
Objectives To investigate the timing (mid‐ vs late life) of physical activity, apolipoprotein (APO)E ε4, and risk of incident mild cognitive impairment (MCI).... 
mild cognitive impairment | APOE e4 | physical activity | Apolipoprotein E4 - genetics | Prospective Studies | Humans | Genotype | Male | Risk | Motor Activity | Cognitive Dysfunction - prevention & control | Incidence | Aged, 80 and over | Cognitive Dysfunction - genetics | Female | Surveys and Questionnaires | Aged | Mild Cognitive Impairment | Physical Activity
Journal Article
Neurobiology of aging, ISSN 0197-4580, 2014, Volume 35, Issue 6, pp. 1318 - 1324
Journal Article
Current Alzheimer research, ISSN 1567-2050, 08/2011, Volume 8, Issue 5, pp. 479 - 491
Journal Article